{"id":25731,"date":"2024-10-02T15:42:02","date_gmt":"2024-10-02T13:42:02","guid":{"rendered":"https:\/\/mabdesign.fr\/?p=25731"},"modified":"2025-03-27T10:57:08","modified_gmt":"2025-03-27T09:57:08","slug":"breast-cancer","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/breast-cancer\/","title":{"rendered":"breast cancer"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

MabDesign’s market analyses give you a monthly overview of market dynamics and projects<\/span> in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. For this month of pink October, we take a look at the market and projects currently under development for the treatment of breast cancer. <\/span><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Breast cancer is the most common cancer in women: it accounts for more than a third of all cancers in women, and is also the leading cause of cancer-related death in women<\/strong>. According to the WHO, in 2022, 2.3 million cases were diagnosed<\/strong>, causing 670,000 deaths worldwide<\/strong>. Screening programmes that have been in place for several years have nevertheless helped to reduce mortality in countries with a high human development index. <\/p>\n

Breast cancers are often classified according to immunohistochemical criteria, with three main categories: hormone-dependent cancers<\/strong> (70-80%), i.e. positive for oestrogen and\/or progesterone receptors, HER2+ cancers<\/strong>, and triple-negative cancers<\/strong> (13-20%) having none of these three markers. <\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Epidemiological data<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Breast cancer market<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The vast majority of products on the market indicated for breast cancer are small molecules. However, 28 biomedicines (excluding biosimilars) are currently available: the vast majority are therapeutic proteins, including 13 monoclonal antibodies<\/a><\/strong> and 3 antibody-drug conjugates.<\/a><\/strong> <\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Products on the market<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
biologics (excluding biosimilars)<\/div>\t\t\t
\n\t\t\t\t<\/span>\n\t\t\t\t0<\/span>\n\t\t\t\t<\/span>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"mAbs\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
mAbs<\/div>\t\t\t
\n\t\t\t\t<\/span>\n\t\t\t\t0<\/span>\n\t\t\t\t<\/span>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"ADC\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
ADCs<\/div>\t\t\t
\n\t\t\t\t<\/span>\n\t\t\t\t0<\/span>\n\t\t\t\t<\/span>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

active breast cancer pipeline<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The pipeline is rich, and as for the products on the market overall, it is dominated by antibody-based strategies<\/strong>: 34% of products are monoclonal antibodies, and 19% are antibody-drug conjugates (ADCs). On the other hand,<\/span> ATMPs<\/a> <\/strong>such as cell therapies (5%) and genetically modified cell therapies (10%) are appearing in the pipeline.<\/span><\/p>\n

In terms of indication, the projects in the pipeline mainly target <\/span>triple-negative breast cancer (35%)<\/span>,<\/b> followed by metastatic cancers (15%) and HER2+ cancers (10%).<\/span> <\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

35%<\/strong><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

triple negative breats cancer<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

15%<\/strong><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

metastatic cancer<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

10%<\/strong><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

HER2+ cancer<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t<\/canvas>\n\t\t<\/div>\n\n\t\t
<\/h5><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Download our infographic<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Breast cancer market<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"march\u00e9\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
<\/path><\/svg><\/span>Download in .pdf format<\/span><\/span><\/small><\/span><\/a>\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Want to find out more? <\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

MabDesign has acquired and cultivates its expertise in all market segments associated with biopharmaceuticals and biomanufacturing. Our team<\/a> of consultants is at your disposal to support you in all your biotherapy-related projects. Feel free to explore our range of services<\/a>, including our marketing and strategic analyses<\/a>, if you’d like to find out more!<\/i><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tContact us<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Sources: MabDesign & GlobalData<\/p>\n

Date – September 2024<\/span><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

The MabDesign market analysis for this month of pink October gives you an overview of market dynamics and projects in development targeting the treatment of breast cancer.<\/p>\n","protected":false},"author":4,"featured_media":25590,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[83,88,119],"tags":[170,257,98,141,157,259,159,255,256],"class_list":["post-25731","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analyses-marche","category-bio-hub-en","category-market-analysis-en","tag-breast-cancer","tag-cell-and-gene-therapy","tag-innovation-en","tag-market","tag-oncology-en","tag-other-biologics","tag-pipeline-analysis-en","tag-therapeutic-antibodies-and-proteins","tag-vaccines-en"],"yoast_head":"\nMarket breast cancer - MabDesign<\/title>\n<meta name=\"description\" content=\"For pink October, the MabDesign market analysis gives you an overview of the market and projects in development targeting breast cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Market breast cancer - MabDesign\" \/>\n<meta property=\"og:description\" content=\"For pink October, the MabDesign market analysis gives you an overview of the market and projects in development targeting breast cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-02T13:42:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-27T09:57:08+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/10\/Breast-Cancer-October-5.png\" \/>\n\t<meta property=\"og:image:width\" content=\"3375\" \/>\n\t<meta property=\"og:image:height\" content=\"4500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Anabelle Perrier\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anabelle Perrier\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/breast-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/breast-cancer\/\"},\"author\":{\"name\":\"Anabelle Perrier\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/4643f9d895805d8377e2471c8e4d6918\"},\"headline\":\"breast cancer\",\"datePublished\":\"2024-10-02T13:42:02+00:00\",\"dateModified\":\"2025-03-27T09:57:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/breast-cancer\/\"},\"wordCount\":373,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/breast-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/10\/Breast-Cancer-October-5.png\",\"keywords\":[\"breast cancer\",\"Cell and Gene therapy\",\"innovation\",\"market\",\"oncology\",\"Other Biologics\",\"pipeline analysis\",\"Therapeutic antibodies and proteins\",\"Vaccines\"],\"articleSection\":[\"Analyses march\u00e9\",\"Bio-hub\",\"Market analysis\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/breast-cancer\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/breast-cancer\/\",\"name\":\"Market breast cancer - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/breast-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/breast-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/10\/Breast-Cancer-October-5.png\",\"datePublished\":\"2024-10-02T13:42:02+00:00\",\"dateModified\":\"2025-03-27T09:57:08+00:00\",\"description\":\"For pink October, the MabDesign market analysis gives you an overview of the market and projects in development targeting breast cancer.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/breast-cancer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/breast-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/breast-cancer\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/10\/Breast-Cancer-October-5.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/10\/Breast-Cancer-October-5.png\",\"width\":3375,\"height\":4500,\"caption\":\"march\u00e9 cancer du sein, cancer du sein, analyse march\u00e9\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/breast-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"breast cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/4643f9d895805d8377e2471c8e4d6918\",\"name\":\"Anabelle Perrier\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f3a0b000cbed04b58d93c3453cafdf5ef34c998ff91ba6a81b173a075a0bfae2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f3a0b000cbed04b58d93c3453cafdf5ef34c998ff91ba6a81b173a075a0bfae2?s=96&d=mm&r=g\",\"caption\":\"Anabelle Perrier\"},\"url\":\"https:\/\/mabdesign.fr\/en\/author\/anabelle-perriermabdesign-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Market breast cancer - MabDesign","description":"For pink October, the MabDesign market analysis gives you an overview of the market and projects in development targeting breast cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/breast-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Market breast cancer - MabDesign","og_description":"For pink October, the MabDesign market analysis gives you an overview of the market and projects in development targeting breast cancer.","og_url":"https:\/\/mabdesign.fr\/en\/breast-cancer\/","og_site_name":"MabDesign","article_published_time":"2024-10-02T13:42:02+00:00","article_modified_time":"2025-03-27T09:57:08+00:00","og_image":[{"width":3375,"height":4500,"url":"http:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/10\/Breast-Cancer-October-5.png","type":"image\/png"}],"author":"Anabelle Perrier","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"Anabelle Perrier","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/breast-cancer\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/breast-cancer\/"},"author":{"name":"Anabelle Perrier","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/4643f9d895805d8377e2471c8e4d6918"},"headline":"breast cancer","datePublished":"2024-10-02T13:42:02+00:00","dateModified":"2025-03-27T09:57:08+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/breast-cancer\/"},"wordCount":373,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/10\/Breast-Cancer-October-5.png","keywords":["breast cancer","Cell and Gene therapy","innovation","market","oncology","Other Biologics","pipeline analysis","Therapeutic antibodies and proteins","Vaccines"],"articleSection":["Analyses march\u00e9","Bio-hub","Market analysis"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/breast-cancer\/","url":"https:\/\/mabdesign.fr\/en\/breast-cancer\/","name":"Market breast cancer - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/breast-cancer\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/10\/Breast-Cancer-October-5.png","datePublished":"2024-10-02T13:42:02+00:00","dateModified":"2025-03-27T09:57:08+00:00","description":"For pink October, the MabDesign market analysis gives you an overview of the market and projects in development targeting breast cancer.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/breast-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/breast-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/breast-cancer\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/10\/Breast-Cancer-October-5.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/10\/Breast-Cancer-October-5.png","width":3375,"height":4500,"caption":"march\u00e9 cancer du sein, cancer du sein, analyse march\u00e9"},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"breast cancer"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/4643f9d895805d8377e2471c8e4d6918","name":"Anabelle Perrier","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f3a0b000cbed04b58d93c3453cafdf5ef34c998ff91ba6a81b173a075a0bfae2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f3a0b000cbed04b58d93c3453cafdf5ef34c998ff91ba6a81b173a075a0bfae2?s=96&d=mm&r=g","caption":"Anabelle Perrier"},"url":"https:\/\/mabdesign.fr\/en\/author\/anabelle-perriermabdesign-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/25731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=25731"}],"version-history":[{"count":8,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/25731\/revisions"}],"predecessor-version":[{"id":25756,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/25731\/revisions\/25756"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/25590"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=25731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=25731"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=25731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}